Astellas Pharma Inc: all 983 studies
Page 3 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.
- Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell TransplantCompletedNCT06734585
- A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid TumorsWithdrawnNCT06681870Phase 1
- A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's SyndromeTerminatedNCT06544642Phase 1
- A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi ArabiaCompletedNCT06505746
- Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer PatientsCompletedNCT06500741
- A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich AtaxiaWithdrawnNCT06483802Phase 1
- Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer PatientsCompletedNCT06452212
- A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyActive, not recruitingNCT06440967Phase 3
- A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic CancerActive, not recruitingNCT06396091Phase 1
- A Study to Find a Suitable Dose of ASP4396 in Adults With Solid TumorsTerminatedNCT06364696Phase 1
- A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell LymphomasTerminatedNCT06248086Phase 1
- A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through MenopauseCompletedNCT06206421Phase 3
- A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through MenopauseCompletedNCT06206408Phase 3
- A Study of ASP1012 in Adults With Solid TumorsTerminatedNCT06171178Phase 1
- A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe DiseaseActive, not recruitingNCT06150820Not applicable
- A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night SweatsCompletedNCT06049797
- A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney DiseaseCompletedNCT05999747Phase 3
- A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseActive, not recruitingNCT05970172Phase 3
- A Study of ASP2074 in Adults With Solid TumorsTerminatedNCT05646797Phase 1
- A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor OveractivityCompletedNCT05621616Phase 3
- Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database AnalysisCompletedNCT05530291
- A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaActive, not recruitingNCT05520567Phase 1/2
- A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work WellCompletedNCT05495581Phase 1
- Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) StudyCompletedNCT05381311
- A Survey About Trade-offs When Choosing Menopause TreatmentsCompletedNCT05300568
- A Study to Learn How [14C]ASP0367 is Processed by the Body in Healthy MenCompletedNCT05217901Phase 1
- A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy AdultsTerminatedNCT05167526Phase 1
- A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05153915Phase 4
- A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05152628Phase 4
- A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy PeopleCompletedNCT05117294Phase 1
- A Survey About Hot Flashes in Women Going Through the MenopauseCompletedNCT05083884
- A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid TumorsTerminatedNCT05083481Phase 1
- A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use DisorderWithdrawnNCT05062577Phase 2
- A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through MenopauseCompletedNCT05034042Phase 2
- A Study of Fezolinetant to Treat Hot Flashes in Women Going Through MenopauseCompletedNCT05033886Phase 3
- A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) RegisterCompletedNCT05015998
- A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)TerminatedNCT05014139Phase 1
- A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic FunctionCompletedNCT04942964Phase 1
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male ParticipantsCompletedNCT04878471Phase 1
- A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionTerminatedNCT04855201Phase 1
- A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female SubjectsCompletedNCT04793204Phase 1
- A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly SubjectsCompletedNCT04742517Phase 1
- A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal FunctionCompletedNCT04699877Phase 1
- A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) MutationCompletedNCT04691648
- A Study to Assess the Effect of Food With Fezolinetant in Healthy Female ParticipantsCompletedNCT04641260Phase 1
- A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)CompletedNCT04553029
- A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic FunctionCompletedNCT04482270Phase 1
- A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal FunctionCompletedNCT04476849Phase 1
- A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With MenopauseCompletedNCT04451226Phase 3
- Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal AnemiaCompletedNCT04408820
- A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female ParticipantsCompletedNCT04277624Phase 1
- A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through MenopauseCompletedNCT04234204Phase 3
- A Study to Assess Effect of Exercise Program Provided by Smartphone Application on the Body CompositionCompletedNCT04194697Not applicable
- A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust MitesActive, not recruitingNCT04184895Phase 1
- A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)TerminatedNCT04184882Phase 1
- Gene Transfer Study in Patients With Late Onset Pompe DiseaseActive, not recruitingNCT04174105Phase 1/2
- A Study to Evaluate the Pharmacokinetics and Safety of ASP015K in Healthy Chinese SubjectsCompletedNCT04143477Phase 1
- An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial CarcinomaApproved for marketingNCT04136808
- A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy ParticipantsCompletedNCT04096157Phase 1
- A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate CancerCompletedNCT04094519Phase 1
- Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid TumorsCompletedNCT04094506Phase 1
- A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaCompletedNCT04086758Phase 1
- Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food EffectCompletedNCT04077879Phase 1
- Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on DialysisCompletedNCT04042350
- A Study to Assess ASP2713 in Healthy SubjectsWithdrawnNCT04017208Phase 1
- A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult SubjectsCompletedNCT04003402Phase 1
- Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid ArthritisCompletedNCT03971253
- A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy SubjectsCompletedNCT03964038Phase 1
- A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult SubjectsCompletedNCT03960489Phase 1
- A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid TumorsCompletedNCT03954067Phase 1
- Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid TumorsCompletedNCT03945253Phase 1
- A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic BurdenCompletedNCT03903094
- A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic CancerActive, not recruitingNCT03816163Phase 2
- A Study of ASP1951 in Subjects With Advanced Solid TumorsTerminatedNCT03799003Phase 1
- A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid VaccineCompletedNCT03755713Phase 1
- A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)CompletedNCT03737708Phase 4
- A Study of ASP8302 in Participants With Underactive BladderCompletedNCT03702777Phase 2
- A Study in Healthy Adult Volunteers to Assess the Safety and Pharmacokinetics of an Investigational Imaging ProductCompletedNCT03698305Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect CohortCompletedNCT03682484Phase 1
- A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)CompletedNCT03660059Phase 3
- Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant RecipientsCompletedNCT03644485Phase 4
- A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney DiseaseCompletedNCT03643601
- Development of Visual Function Evaluation Method (2)CompletedNCT03626207
- Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney TransplantationCompletedNCT03623217
- A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or DeathCompletedNCT03619980
- Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia OceaniaCompletedNCT03602508
- A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and ChinaCompletedNCT03572231
- A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid TumorsCompletedNCT03565445Phase 1
- A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaCompletedNCT03528629Not applicable
- A Study of Zolbetuximab (IMAB362) in Adults With Gastric CancerActive, not recruitingNCT03505320Phase 2
- Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)CompletedNCT03471728
- A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant PatientsCompletedNCT03465969Phase 4
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female SubjectsCompletedNCT03436849Phase 1
- Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida MeningitisCompletedNCT03421002Phase 2
- Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)No longer availableNCT03409081
- A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar DisorderCompletedNCT03403790
- ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)WithdrawnNCT03374670Phase 2
- ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese SubjectsCompletedNCT03361540Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With SchizophreniaCompletedNCT03356639Phase 1
- A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in SwedenCompletedNCT03328364